- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05048316
Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors
April 13, 2023 updated by: H. Lee Moffitt Cancer Center and Research Institute
Pilot Study to Develop a Group-Based E-Health Intervention for Young Adult Cancer Survivors
Investigators will test an evidence-based behavioral intervention that is responsive to Young Adults (YA's) expressed needs and priorities
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
17
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Tampa, Florida, United States, 33612
- Moffitt Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 18-39 years old
- Diagnosed with cancer between 18-39 years old
- Cancer diagnosis was non-metastatic
- Completed cancer treatment between 1 month and 5 years prior to enrollment, with the exception of ongoing hormone therapy
- No documented or observable psychiatric or neurological disorders that could interfere with participation (e.g., active psychosis, active substance abuse), as identified by the referring medical team, chart review, or screening
- Able to speak and read English
- Able to provide informed consent
Exclusion Criteria:
- Metastatic disease
- Continued cancer treatment
- Psychiatric or neurological disorders that could interfere with study participation
- Vulnerable populations will not be included
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: eHealth
Weekly video conference groups led by a trained facilitator
|
Participants will attend group sessions with a trained facilitator held over videoconference.
Sessions will each last 2 hours and will be held once weekly for 10 weeks.
Sessions will include Cognitive-Behavioral Stress Management and health education content.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction assessed by study-specific survey during the intervention - Acceptability
Time Frame: During intervention
|
The intervention will be deemed acceptable if, on average, participants report satisfaction with the weekly sessions as ≥2 on a 0-4 scale.
|
During intervention
|
|
Satisfaction assessed by study-specific survey after the intervention - Acceptability
Time Frame: Immediately after the intervention
|
The intervention will be deemed acceptable if, on average, participants report satisfaction with the overall program and intent to continue using the intervention skills as ≥2 on a 0-4 scale.
|
Immediately after the intervention
|
|
Session attendance after the intervention - Acceptability
Time Frame: Immediately after the intervention
|
Videoconference delivery will be acceptable if average group attendance is ≥6/10 sessions.
|
Immediately after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of life before intervention
Time Frame: Baseline
|
Participants will complete the 27-item Functional Assessment of Cancer Therapy - General
|
Baseline
|
|
Change in quality of life at after intervention
Time Frame: Immediately after intervention
|
Participants will complete the 27-item Functional Assessment of Cancer Therapy - General
|
Immediately after intervention
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Symptom burden before intervention
Time Frame: Baseline
|
Participants will complete the 22-item Impact of Event Scale-Revised
|
Baseline
|
|
Change in Symptom burden after intervention
Time Frame: Immediately after intervention
|
Participants will complete the 22-item Impact of Event Scale-Revised
|
Immediately after intervention
|
|
Cancer-related distress before intervention
Time Frame: Baseline
|
Participants will complete the 22-item Impact of Event Scale-Revised
|
Baseline
|
|
Change in cancer-related distress after intervention
Time Frame: Immediately after intervention
|
Participants will complete the 22-item Impact of Event Scale-Revised
|
Immediately after intervention
|
|
Stress management skills self-efficacy before intervention
Time Frame: Baseline
|
Participants will complete subscales from the Measure of Current Status
|
Baseline
|
|
Change in stress management skills self-efficacy after intervention
Time Frame: Immediately after intervention
|
Participants will complete subscales from the Measure of Current Status
|
Immediately after intervention
|
|
Coping before intervention
Time Frame: Baseline
|
Participants will complete the Brief-COPE
|
Baseline
|
|
Change in coping after intervention
Time Frame: Immediately after intervention
|
Participants will complete the Brief-COPE
|
Immediately after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 11, 2021
Primary Completion (Actual)
January 6, 2022
Study Completion (Actual)
January 6, 2022
Study Registration Dates
First Submitted
August 31, 2021
First Submitted That Met QC Criteria
September 8, 2021
First Posted (Actual)
September 17, 2021
Study Record Updates
Last Update Posted (Actual)
April 14, 2023
Last Update Submitted That Met QC Criteria
April 13, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- MCC-21053
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer Survivor
-
University of New MexicoNew Mexico State University; University of New Mexico Cancer CenterCompleted
-
Ohio State University Comprehensive Cancer CenterCompletedCancer SurvivorUnited States
-
University Health Network, TorontoPrincess Margaret Hospital, Canada; Canadian Breast Cancer FoundationCompletedBreast Cancer Survivor | Pediatric Cancer SurvivorCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Oncology Nursing Society; Villanova UniversityCompletedChildhood Cancer SurvivorUnited States
-
Turku University HospitalLounais-Suomen SyöpäyhdistysNot yet recruiting
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnCancer SurvivorUnited States
-
University of Alabama at BirminghamNational Cancer Institute (NCI); Auburn UniversityCompleted
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedCancer SurvivorUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); National Institute of Mental Health (NIMH)CompletedCancer SurvivorUnited States
Clinical Trials on Cognitive-Behavioral Stress Management and Health Education
-
University of ArizonaCompletedCancerUnited States
-
Northwestern UniversityAmerican Cancer Society, Inc.Completed
-
Changzhi Medical CollegeNot yet recruitingPsychological Stress | Nursing Students
-
US Department of Veterans AffairsTerminatedAnger | Stress | Arrhythmia | Cardiomyopathy, DilatedUnited States
-
University Hospital, GrenobleFondation de FranceEnrolling by invitationBurnout, CaregiverFrance
-
National Institute on Drug Abuse (NIDA)CompletedHIV/AIDS | Drug Abuse | Alcohol Abuse
-
Milton S. Hershey Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Georgetown... and other collaboratorsCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | StressUnited States
-
National Jewish HealthCompletedDepression | Stress | Anxiety | Cystic Fibrosis | Coping SkillsUnited States
-
Kovacs FoundationHospital Laboral SOLIMATTerminated